• Je něco špatně v tomto záznamu ?

Hypoxia favors myosin heavy chain beta gene expression in an Hif-1alpha-dependent manner

L. Binó, J. Procházková, KA. Radaszkiewicz, J. Kučera, J. Kudová, J. Pacherník, L. Kubala,

. 2017 ; 8 (48) : 83684-83697. [pub] 20170705

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18000944

The potentiation of the naturally limited regenerative capacity of the heart is dependent on an understanding of the mechanisms that are activated in response to pathological conditions such as hypoxia. Under these conditions, the expression of genes suggested to support cardiomyocyte survival and heart adaptation is triggered. Particularly important are changes in the expression of myosin heavy chain (MHC) isoforms. We propose here that alterations in the expression profiles of MHC genes are induced in response to hypoxia and are primarily mediated by hypoxia inducible factor (HIF). In in vitro models of mouse embryonic stem cell-derived cardiomyocytes, we showed that hypoxia (1% O2) or the pharmacological stabilization of HIFs significantly increased MHCbeta (Myh7) gene expression. The key role of HIF-1alpha is supported by the absence of these effects in HIF-1alpha-deficient cells, even in the presence of HIF-2alpha. Interestingly, ChIP analysis did not confirm the direct interaction of HIF-1alpha with putative HIF response elements predicted in the MHCalpha and beta encoding DNA region. Further analyses showed the significant effect of the mTOR signaling inhibitor rapamycin in inducing Myh7 expression and a hypoxia-triggered reduction in the levels of antisense RNA transcripts associated with the Myh7 gene locus. Overall, the recognized and important role of HIF in the regulation of heart regenerative processes could be highly significant for the development of novel therapeutic interventions in heart failure.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18000944
003      
CZ-PrNML
005      
20241217090143.0
007      
ta
008      
180116s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.18632/oncotarget.19016 $2 doi
035    __
$a (PubMed)29137374
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Binó, Lucia $u Institute of Biophysics of the CAS, Brno, Czech Republic. Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic. $7 xx0326742
245    10
$a Hypoxia favors myosin heavy chain beta gene expression in an Hif-1alpha-dependent manner / $c L. Binó, J. Procházková, KA. Radaszkiewicz, J. Kučera, J. Kudová, J. Pacherník, L. Kubala,
520    9_
$a The potentiation of the naturally limited regenerative capacity of the heart is dependent on an understanding of the mechanisms that are activated in response to pathological conditions such as hypoxia. Under these conditions, the expression of genes suggested to support cardiomyocyte survival and heart adaptation is triggered. Particularly important are changes in the expression of myosin heavy chain (MHC) isoforms. We propose here that alterations in the expression profiles of MHC genes are induced in response to hypoxia and are primarily mediated by hypoxia inducible factor (HIF). In in vitro models of mouse embryonic stem cell-derived cardiomyocytes, we showed that hypoxia (1% O2) or the pharmacological stabilization of HIFs significantly increased MHCbeta (Myh7) gene expression. The key role of HIF-1alpha is supported by the absence of these effects in HIF-1alpha-deficient cells, even in the presence of HIF-2alpha. Interestingly, ChIP analysis did not confirm the direct interaction of HIF-1alpha with putative HIF response elements predicted in the MHCalpha and beta encoding DNA region. Further analyses showed the significant effect of the mTOR signaling inhibitor rapamycin in inducing Myh7 expression and a hypoxia-triggered reduction in the levels of antisense RNA transcripts associated with the Myh7 gene locus. Overall, the recognized and important role of HIF in the regulation of heart regenerative processes could be highly significant for the development of novel therapeutic interventions in heart failure.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Procházková, Jiřina $u Institute of Biophysics of the CAS, Brno, Czech Republic. Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Radaszkiewicz, Katarzyna $u Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic. $7 xx0320047
700    1_
$a Kučera, Jan $u Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic. International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Kudová, Jana $u Institute of Biophysics of the CAS, Brno, Czech Republic. Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic. International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Pacherník, Jiří $u Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Kubala, Lukáš $u Institute of Biophysics of the CAS, Brno, Czech Republic. Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic. International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Brno, Czech Republic.
773    0_
$w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 8, č. 48 (2017), s. 83684-83697
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29137374 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180116 $b ABA008
991    __
$a 20241217090139 $b ABA008
999    __
$a ind $b bmc $g 1268339 $s 997606
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 8 $c 48 $d 83684-83697 $e 20170705 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
LZP    __
$a Pubmed-20180116

Najít záznam

Citační ukazatele

Možnosti archivace